R & D of new coronavirus, a and B combined detection kits completed

Wen Feng mound Novel coronavirus pneumonia was reported in Guangzhou on February 23rd afternoon In a remote consultation with the Guangdong medical team in Jingzhou, Zhong Nanshan pointed out that the current influenza pandemic in the United States is far higher than that of the new crown pneumonia cases A pressing matter of the moment is China's novel coronavirus pneumonia 22, the novel coronavirus novel coronavirus monitoring product from 3 enterprises was also examined and approved by the State Administration of drug administration 2 colloidal gold antibody detection reagents and 1 isothermal amplification chip nucleic acid detection reagents were expanded, and the detection methods and means of new coronavirus were expanded in 3 Novel coronavirus novel coronavirus detection kit (novel coronavirus amplification method) has been approved for boto's bio detection of six new suspected coronavirus cases, suspected cluster cases, and other new coronavirus infection diagnostic and differential diagnostic swabs, including new coronavirus S and N target genes and influenza A (H1N1) Virus, new influenza A H1N1 virus (2009), influenza A H3N2 virus, influenza B virus, respiratory syncytial virus nucleic acid On the afternoon of the 23rd, Kaipu biology announced that the R & D team of Guangzhou Kaipu Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary, has also recently developed "new coronavirus covid-19, influenza A (flu a)" through a closed, automated and high-throughput nucleic acid extraction and amplification system based on the fluorescence quantitative PCR platform And influenza B (flub) combined with nucleic acid detection kit (fluorescent PCR) The novel coronavirus is mainly used for detection of influenza A virus, influenza B virus and new coronavirus COVID-19 Taking human RNA internal reference B2M as internal reference, it is used to monitor the collection and extraction effect of samples, avoid false negative results, set up anti pollution measures of ung enzyme + dUTP, avoid false positive results caused by PCR product pollution, and extract RNA based on automatic nucleic acid extraction system after collection of samples, which is safe and fast in operation and reduces the risk of infection of operators The novel coronavirus pneumonia can be satisfied with the rapid detection and the seasonal effect of influenza However, according to the announcement, the product has not yet obtained the medical device registration certificate and is only used for scientific research In addition, one novel coronavirus antibody test reagent was obtained from 2 IgM/IgG, and it was used for the qualitative detection of the new coronavirus antibody (IgM/IgG) in human serum, plasma and whole blood samples in vitro The other is from innot, as follows: